‘Another benefit’: The pill shown to reduce ovarian cancer risk Australian research finds the oral contraceptive pill can reduce risk of the cancer by 26% among women who have used it at any age.
GP’s research shedding light on end-of-life care On World Cancer Day, one GP’s innovative research is transforming care for cancer patients in their final months of life.
Alcohol and pregnancy campaign benefit estimated at $236 million New analysis has suggested a public awareness campaign aimed at pregnant women is having significant financial and wellbeing advantages.
Examining the pros and cons of semaglutide A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
GP clinic’s research drives positive change in patient care ‘Research shouldn’t just be about academics; it should be about real-world improvements,’ says one GP changing her community.
Call for ‘soft launch’ of lung cancer screening program The RACGP’s call comes ahead of a new national program, with a ‘slow build-up of screening’ urged to mitigate extra GP workload.
World experts urge overhaul of obesity definition The Global Commission on Clinical Obesity says diagnosis must change, setting out new criteria, categories, and calling on doctors to go ‘beyond BMI’.
2024’s top general practice stories From Wegovy and Mounjaro, to tongue cancer, RSV, and vitamin B toxicity, what were the stories most read by GPs this year?
Registered nurses’ prescribing powers expanded Nurses who have undergone extra training will soon be able to work to a broader scope of practice under a new prescriber arrangement.
‘It’s completely filled my cup’: PRIDoC 2024 wraps up The Pacific Region Indigenous Doctors Congress was an opportunity for ‘transnational knowledge sharing and solidarity building’.